RE:RE:RE:RE:JustASimpleGuy,Like you, based upon the production expectation from their streaming partners, I've never really had much of an issue from that point of view.
I have mentioned on a few occasions though, that they really need to start to focus in on their sales and distribution activities. Although it does sound like they have a done deal in place with Inner Spirit (personally never heard of them) along with something in the form of an apparent exclusive contract with some unmaned pharmacy chain.
Not sure how much of this massive cannabis volume of product we will be able to sell through these 2 companies though. Apparently, APH will also be shipping 15M grams of cannabis to Navisent (a subsidary of CBW) formed for the purposes of establishing international distribution channels.
So yes, the sales and distribution channels are still definitely a work in progress as there is no point in pumping out 550M grams on cannabis per annum if you have nothing in place to do anything significant with it after that.
JustASimpleGuy wrote: longonMJ wrote:
It's just kind of sad to see this company with all of these agreements and LOI's in place, and yet seems to get absolutely no coverage at all in the media. Unfortunately, this lack of hype and media coverage seems to be relected in their relatively depressed valuation.
Yet at the same time, a company like Aurora which would appear to have a lot less in terms of production capacity seems to have their hype department working on full steam as these guys always tend to find some way to get themselves into the news almost every day. This is even for non-stories that really doesn't amount to much at all. All of this media attention and name recognition is probably one of the reasons for the high valuation on this company even though their overall sales is still nothing to write home about.
Maybe CBW needs to hire themselves an information (i.e. propoganda) officer like Cam Battley to get out their story. Hmmm.....
As I see it Aurora's been around since 2014, has three cultivation and one sales licence for plants/dried, a production and sales license for fresh/oils and in 2017 looks like they had roughly $18M (USD I think) in revenue.
CBW has barely been in the game for a year, I don't believe they have a single partner with a sales license locked down and no revenue to speak of. Yet. Revenue shouldn't be too far away, especially with the Aphria distribution and Inverell deals. Beleave should also be close to a sales license and I think Artiva is as well. The potential is exciting and now it's all down to execution for both CBW and its partners.